NINA MAW MAW: Open Payments
NPI 1407851777 · RANCHO MIRAGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 25 payments from 12 companies in 2025. Trend: 2023 $371 · 2024 $398 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $169 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $152 |
| Abbott Laboratories | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
| Lilly USA, LLC | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Novo Nordisk Inc | 1 | $27 |
| Baxter Healthcare | 1 | $25 |
| Currax Pharmaceuticals LLC | 1 | $17 |
Products named: Kerendia, AIRSUPRA, WAINUA, FREESTYLE LIBRE 3, LEQVIO, TRELEGY ELLIPTA, ZEPBOUND, CAMZYOS.
Industry payments across CA — which companies pay providers there.
